These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 3148815

  • 1. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.
    Welkos SL, Friedlander AM.
    Microb Pathog; 1988 Aug; 5(2):127-39. PubMed ID: 3148815
    [Abstract] [Full Text] [Related]

  • 2. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Ivins BE, Welkos SL, Knudson GB, Little SF.
    Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269
    [Abstract] [Full Text] [Related]

  • 3. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S, Little S, Friedlander A, Fritz D, Fellows P.
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [Abstract] [Full Text] [Related]

  • 4. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A.
    Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC, Köhler SM, Crafford J, van Heerden H, Beyer W.
    Vet Immunol Immunopathol; 2016 Oct 01; 178():14-21. PubMed ID: 27496738
    [Abstract] [Full Text] [Related]

  • 6. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.
    Infect Immun; 2007 Nov 01; 75(11):5425-33. PubMed ID: 17646360
    [Abstract] [Full Text] [Related]

  • 7. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 01; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 8. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.
    Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z.
    Infect Immun; 2002 Feb 01; 70(2):544-60. PubMed ID: 11796581
    [Abstract] [Full Text] [Related]

  • 9. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino SI.
    Microbiology (Reading); 2006 Oct 01; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [Abstract] [Full Text] [Related]

  • 10. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
    Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW.
    Infect Immun; 2009 Apr 01; 77(4):1649-63. PubMed ID: 19168734
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.
    Infect Immun; 2009 Mar 01; 77(3):1197-207. PubMed ID: 19114543
    [Abstract] [Full Text] [Related]

  • 12. Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.
    Chitlaru T, Israeli M, Bar-Haim E, Elia U, Rotem S, Ehrlich S, Cohen O, Shafferman A.
    Sci Rep; 2016 Jan 06; 6():18908. PubMed ID: 26732659
    [Abstract] [Full Text] [Related]

  • 13. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against B. anthracis Spores and Toxin.
    Majumder S, Das S, Somani VK, Makam SS, Kingston JJ, Bhatnagar R.
    Front Immunol; 2019 Jan 06; 10():498. PubMed ID: 30941133
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I, Bar-David E, Sittner A, Weiss S, Schlomovitz J, Ben-Shmuel A, Mechaly A, Altboum Z, Kobiler D, Levy H.
    Antimicrob Agents Chemother; 2016 Aug 06; 60(8):4878-85. PubMed ID: 27270276
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
    Vergis JM, Cote CK, Bozue J, Alem F, Ventura CL, Welkos SL, O'Brien AD.
    Clin Vaccine Immunol; 2013 Jan 06; 20(1):56-65. PubMed ID: 23114705
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
    Little SF, Knudson GB.
    Infect Immun; 1986 May 06; 52(2):509-12. PubMed ID: 3084385
    [Abstract] [Full Text] [Related]

  • 19. Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine.
    Phaswana PH, Ndumnego OC, Koehler SM, Beyer W, Crafford JE, van Heerden H.
    Vet Res; 2017 Sep 07; 48(1):46. PubMed ID: 28882176
    [Abstract] [Full Text] [Related]

  • 20. Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.
    Aloni-Grinstein R, Gat O, Altboum Z, Velan B, Cohen S, Shafferman A.
    Infect Immun; 2005 Jul 07; 73(7):4043-53. PubMed ID: 15972492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.